TNFSF10 and colonic neoplasm: Co-treatment with EGCG and TRAIL, of highly aggressive colon cancer cells, synergistically increased cytotoxicity, by upregulation of death receptors DR5 and activation of caspase 8 [44], demonstrating that EGCG can be a potent TRAIL sensitizer.